Seshadri N, Robinson K
Department of Cardiology, Cleveland Clinic Foundation, Ohio, USA.
Med Clin North Am. 2000 Jan;84(1):215-37, x. doi: 10.1016/s0025-7125(05)70215-7.
This article discusses the metabolism of homocysteine, factors affecting its plasma level, and the evidence for its role in the pathogenesis of vascular disease. The treatment of hyperhomocysteinemia and its possible impact on vascular disease prevention and progression are described also.